# OnCo record deciphera (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/deciphera/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "deciphera" ;
  schema:name "Deciphera Pharmaceuticals (Ono)"@en ;
  schema:description "Kinase-switch-control company behind ripretinib for GIST and vimseltinib for tenosynovial giant cell tumour; bought by Ono Pharmaceutical in 2024."@en ;
  schema:url <https://onco.cc/companies/deciphera/>, <https://www.deciphera.com> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://www.deciphera.com> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/sarcoma/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/ripretinib/>, <https://onco.cc/drugs/vimseltinib/>, <https://onco.cc/drugs/inlexisertib/> ;
  onco:trials <https://onco.cc/trials/nct03069469/>, <https://onco.cc/trials/nct06948448/>, <https://onco.cc/trials/nct07429266/>, <https://onco.cc/trials/nct03036098/>, <https://onco.cc/trials/nct04078295/>, <https://onco.cc/trials/nct03673501/>, <https://onco.cc/trials/nct05144854/>, <https://onco.cc/trials/nct06630234/>, <https://onco.cc/trials/nct07734116/>, <https://onco.cc/trials/nct06256328/> .